PODCAST: Why do adenomas recur?

Today's podcast is about silent Corticotropic adenomas and the recurrence rate of these tumors vs. all pituitary adenomas.  Dr. Blevins weighs into a recent...

An informal chat about today’s health insurance’s trials and tribulations

Frustrations with the health insurance industry seem to be steadily increasing for patients and physicians alike as politicians use patients as pawns in a sad,...

Podcast: A review of drugs for tumors that produce ACTH

In this podcast, Dr. Blevins reviews a study conducted at the Ludwig Maximilian University of Munich, Germany on pituitary tumor therapeutics and the treatment...

Can oversharing information be the best medicine?

Jay Libove, a privacy and security expert, and pituitary patient discusses privacy and sharing information on social media In today’s new age of digital medicine...

Oxytocin and hypopituitarism

In this podcast, Dr. Blevins dives into a very interesting paper recently published in the Journal of Pituitary, April 2019.  The paper focuses on...

Podcast: the incidence of Cushing’s

In this podcast, we discuss the latest data on the incidence of Cushing's disease worldwide based on a recent Swedish study on the subject, and...

Adult Growth Hormone Deficiency: a talk with Dr. Kevin Yuen

Podcast:  Pituitary World News co-founder Dr. Lewis Blevins talks to Dr. Kevin Yuen, a leading neuroendocrinologist and medical director of the Barrow...

Podcast​: Radiotherapy induce​d hypopituitarism

In this highly informational podcats, Dr. Blevins discussed his experiences with patients that receive radiotherapy and develop hypopituitarism at a later date....

Telemedicine: Opinions, issues, and the future

From the desk of Lewis S Blevins Jr M.D. co-founder - As telemedicine expands, more and more health centers are providing this service to...

Opioids: What should Doctors and Patients do about the crisis?

In this exclusive podcasts, Dr. Blevins talks about his experiences with opiates and the overdose crisis affecting the US today.  He discusses the misuse...

NEWS YOU CAN USE

Articles you may like